原著 |
|
|
|
|
基于SEER数据库建立预测卵巢浆液性囊腺癌术后患者生存时间列线图 |
陈小斌( ),郭婷婷 |
浙江大学医学院附属妇产科医院妇科,浙江 杭州 310006 |
|
Development of a nomogram for predicting survival of patients with ovarian serous cystadenocarcinoma after surgery based on SEER database |
CHEN Xiaobin( ),GUO Tingting |
Department of Obstetrics and Gynecology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China |
1 |
MELAMEDA, MANNING-GEISTB, BREGARA J, et al.Associations between residual disease and survival in epithelial ovarian cancer by histologic type[J]Gynecol Oncol, 2017, 147( 2): 250-256.
doi: 10.1016/j.ygyno.2017.08.003
|
2 |
SINGHA, GUPTAS, SACHANM. Epigenetic biomarkers in the management of ovarian cancer: current prospectives[J]Front Cell Dev Biol, 2019, 182.
doi: 10.3389/fcell.2019.00182
|
3 |
FORTNERR T, OSEJ, MERRITTM A, et al.Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: results from the EPIC cohort[J]Int J Cancer, 2015, 137( 5): 1196-1208.
doi: 10.1002/ijc.29471
|
4 |
KARIMI-ZARCHI M, MORTAZAVIZADEH S M, BASHARDUST N, et al. The clinicopathologic characteristics and 5-year survival rate of epithelial ovarian cancer in yazd, Iran[J]. Electron Physician, 2015, 7(6): 1399-1406
|
5 |
KARABUKE, KOSEM F, HIZLID, et al.Comparison of advanced stage mucinous epithelial ovarian cancer and serous epithelial ovarian cancer with regard to chemosensitivity and survival outcome: a matched case-control study[J]J Gynecol Oncol, 2013, 24( 2): 160.
doi: 10.3802/jgo.2013.24.2.160
|
6 |
KUMPULAINENS, GRéNMANS, KYYR?NENP, et al.Evidence of benefit from centralised treatment of ovarian cancer: a nationwide population-based survival analysis in Finland[J]Int J Cancer, 2002, 102( 5): 541-544.
doi: 10.1002/ijc.10754
|
7 |
SARDIJ E, ANCHEZARP, BERMUDEZA. Favorable clinical behavior in young ovarian carcinoma patients: a rationale for conservative surgery?[J]Int J Gynecol Cancer, 2005, 15( 5): 762-769.
doi: 10.1111/j.1525-1438.2005.00133.x
|
8 |
PECORELLIS, ZIGLIANIL, ODICINOF. Revised FIGO staging for carcinoma of the cervix[J]Int J GynEcol Obstet, 2009, 105( 2): 107-108.
doi: 10.1016/j.ijgo.2009.02.009
|
9 |
刘传忠, 李 力, 赵冰冰. ⅢC~Ⅳ期上皮性卵巢癌预后影响因素分析[J]. 国际妇产科学杂志, 2018, 45(6): 648-651, 657 LIU Chuanzhong, LI Li, ZHAO Bingbing. Analysis of prognostic factors for stage ⅢC or Ⅳ epithelial ovarian cancer[J]. Journal of International Obstetrics and Gynecology, 2018, 45(6): 648-651, 657. (in Chinese)
|
10 |
KIRWANJ M J, TINCELLOD G, HERODJ J O, et al.Effect of delays in primary care referral on survival of women with epithelial ovarian cancer: retrospective audit[J]BMJ, 2002, 324( 7330): 148-151.
doi: 10.1136/bmj.324.7330.148
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|